TruBridge, Inc. (TBRG)

In the past six months, TruBridge's stock has trended down by 1.00%, and in the past month, it decreased by 4.61%. Over the last 12 months, the stock price increased by 0.51%. Key events include earnings guidance revisions in November 2025, August 2025 and May 2024, executive changes with Dawn M. Severance ceasing to be Chief Sales Officer, refinancing of credit facilities, the announcement of third-quarter 2025 results, analyst coverage and ratings from Royal Bank of Canada, Weiss Ratings, BMO Capital Markets, and Zacks Research, and an expanded partnership with RevSpring.

Analysis of TruBridge, Inc. (TBRG) seasonal charts suggests a historical "Buy Date" of December 18 and a "Sell Date" of March 31, which has resulted in a geometric average return of 4.46% above the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. However, this seasonal timeframe correlates poorly with the broader Healthcare sector's period of seasonal strength, which typically runs from April 25 to December 4.

TruBridge, Inc. is a healthcare solutions company operating in the Health Information Services industry. It provides services and technology to community hospitals, clinics, and healthcare systems, primarily in the United States and internationally. The company's business is segmented into Financial Health, Patient Care, and EHR, with the Financial Health segment generating the most revenue. Its major products and services include Revenue Cycle Management (RCM) solutions, Acute Care Solutions, Patient Engagement and Empowerment Technology Solutions, Consulting and Business Management Services, Managed IT Services, Encoder Solutions, and Enterprise Applications.

TruBridge, Inc. provides its healthcare solutions and services to community hospitals, clinics, and other healthcare systems across the United States and internationally. The company's headquarters are located in Mobile, Alabama.

TruBridge has a solid brand reputation, which was a key factor in the company's rebranding from CPSI in March 2024. The rebranding aimed to align products and services with market demand and leverage the trusted name of TruBridge in the healthcare technology sector. TruBridge was honored as one of Modern Healthcare's 2025 Best in Business in the Revenue Cycle Management (RCM) category.

TruBridge, Inc. is a publicly traded company on NASDAQ (TBRG), with institutional investors holding a substantial stake, approximately 65% to 91.66% ownership. Major institutional owners include Vanguard Group Inc., Federated Hermes, Inc., Ameriprise Financial Inc., BlackRock, Inc., JPMorgan Chase & Co., Nellore Capital Management LLC, Dimensional Fund Advisors LP, and Segall Bryant & Hamill LLC. Significant individual and private equity ownership includes L6 Holdings Inc., Ocho Investments LLC, Pinetree Capital Ltd., and CEO Christopher Fowler. The general public holds about 12% ownership.